Real-time enrollment status for this autoimmune polyendocrinopathy candidiasis ectodermal dystrophy enteritis clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 4:52 PM UTC
| NCT Number | NCT07202598 |
| Recruiting Status | Recruiting |
| Condition | Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 2, 2026: Clinical trial NCT07202598 is currently recruiting participants. This phase2 study for autoimmune polyendocrinopathy candidiasis ectodermal dystrophy enteritis is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07202598 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07202598 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.